Följ
Richard A. Larson
Richard A. Larson
professor of Medicine, The University of Chicago
Verifierad e-postadress på medicine.bsd.uchicago.edu
Titel
Citeras av
Citeras av
År
Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia
SG O'Brien, F Guilhot, RA Larson, I Gathmann, M Baccarani, F Cervantes, ...
New England Journal of Medicine 348 (11), 994-1004, 2003
46182003
Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia
BJ Druker, F Guilhot, SG O'Brien, I Gathmann, H Kantarjian, N Gattermann, ...
New England Journal of Medicine 355 (23), 2408-2417, 2006
43722006
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
H Döhner, EH Estey, S Amadori, FR Appelbaum, T Büchner, AK Burnett, ...
Blood, The Journal of the American Society of Hematology 115 (3), 453-474, 2010
42582010
Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic …
BD Cheson, JM Bennett, KJ Kopecky, T Büchner, CL Willman, EH Estey, ...
Journal of clinical oncology 21 (24), 4642-4649, 2003
30072003
European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013
M Baccarani, MW Deininger, G Rosti, A Hochhaus, S Soverini, ...
Blood, The Journal of the American Society of Hematology 122 (6), 872-884, 2013
25412013
Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B
LR Silverman, EP Demakos, BL Peterson, AB Kornblith, JC Holland, ...
Journal of Clinical oncology 20 (10), 2429-2440, 2002
22112002
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid …
JC Byrd, K Mrózek, RK Dodge, AJ Carroll, CG Edwards, DC Arthur, ...
Blood, The Journal of the American Society of Hematology 100 (13), 4325-4336, 2002
20862002
Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia
G Saglio, DW Kim, S Issaragrisil, P Le Coutre, G Etienne, C Lobo, ...
New England Journal of Medicine 362 (24), 2251-2259, 2010
20782010
Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study: Presented in part at …
CL Sawyers, A Hochhaus, E Feldman, JM Goldman, CB Miller, ...
Blood, The Journal of the American Society of Hematology 99 (10), 3530-3539, 2002
15252002
Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia
KR Rai, BL Peterson, FR Appelbaum, J Kolitz, L Elias, L Shepherd, ...
New England Journal of Medicine 343 (24), 1750-1757, 2000
14172000
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
MS Topp, N Gökbuget, AS Stein, G Zugmaier, S O'Brien, RC Bargou, ...
The Lancet Oncology 16 (1), 57-66, 2015
12772015
IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study
G Marcucci, K Maharry, YZ Wu, MD Radmacher, K Mrózek, D Margeson, ...
Journal of clinical oncology 28 (14), 2348, 2010
9472010
International randomized study of interferon vs STI571 (IRIS) 8-year follow up: sustained survival and low risk for progression or events in patients with newly diagnosed …
M Deininger, SG O'Brien, F Guilhot, JM Goldman, A Hochhaus, ...
Blood 114 (22), 1126, 2009
9242009
Adverse Prognostic Significance of KIT Mutations in Adult Acute Myeloid Leukemia With inv(16) and t(8;21): A Cancer and Leukemia Group B Study
P Paschka, G Marcucci, AS Ruppert, K Mrózek, H Chen, RA Kittles, ...
Journal of Clinical Oncology 24 (24), 3904-3911, 2006
8532006
Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer …
SP Whitman, KJ Archer, L Feng, C Baldus, B Becknell, BD Carlson, ...
Cancer research 61 (19), 7233-7239, 2001
8202001
A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811
RA Larson, RK Dodge, CP Burns, EJ Lee, RM Stone, P Schulman, ...
7981995
Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series
SM Smith, MM Le Beau, D Huo, T Karrison, RM Sobecks, J Anastasi, ...
Blood 102 (1), 43-52, 2003
7912003
Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study
RA Larson, BJ Druker, F Guilhot, SG O'Brien, GJ Riviere, T Krahnke, ...
Blood, The Journal of the American Society of Hematology 111 (8), 4022-4028, 2008
7602008
Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia …
JC Byrd, BL Peterson, VA Morrison, K Park, R Jacobson, E Hoke, ...
Blood, The Journal of the American Society of Hematology 101 (1), 6-14, 2003
7352003
Further analysis of trials with azacitidine in patients with myelodysplastic syndrome: studies 8421, 8921, and 9221 by the Cancer and Leukemia Group B
LR Silverman, DR McKenzie, BL Peterson, JF Holland, JT Backstrom, ...
J Clin Oncol 24 (24), 3895-3903, 2006
7082006
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20